• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大样本临床幼年特发性炎性肌病队列的组织学异质性:肌炎自身抗体和病理特征分析。

Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.

机构信息

Infection, Immunity, Inflammation Programme, UCL GOS Institute of Child Health, London, UK.

Division of Neuropathology, UCL Institute of Neurology, London, UK.

出版信息

Neuropathol Appl Neurobiol. 2019 Aug;45(5):495-512. doi: 10.1111/nan.12528. Epub 2019 Mar 11.

DOI:10.1111/nan.12528
PMID:30378704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6767402/
Abstract

AIM

Juvenile idiopathic inflammatory myopathies have been recently reclassified into clinico-serological subgroups. Myopathological correlates of the subgroups are incompletely understood.

METHODS

We studied muscle biopsies from 101 children with clinically and serologically defined juvenile idiopathic inflammatory myopathies from the UK JDM Cohort and Biomarker Study by applying the international JDM score tool, myopathological review and C5b-9 complement analysis.

RESULTS

Autoantibody data were available for 90/101 cases with 18/90 cases positive for anti-TIF1γ, 15/90 anti-NXP2, 11/90 anti-MDA5, 5/90 anti-Mi2 and 6/90 anti-PmScl. JDM biopsy severity scores were consistently low in the anti-MDA5 group, high in the anti-Mi2 group, and widely distributed in the other groups. Biopsies were classified histologically as perifascicular atrophy (22/101), macrophage-rich necrosis (6/101), scattered necrosis (2/101), clustered necrosis (2/101), inflammatory fibre invasion (2/101), chronic myopathic change (1/101), diffuse endomysial macrophage infiltrates (40/101) and minimal change (24/101). MDA5 cases segregated with the minimal change group and showed no capillary C5b-9-deposition. The Mi2 group displayed high severity scores and a tendency towards sarcolemmal complement deposition. NXP2 and TIF1γ groups showed a variety of pathologies with a high proportion of diffuse endomysial macrophage infiltrates and a high proportion of capillary C5b-9 deposition.

CONCLUSION

We have shown that juvenile idiopathic inflammatory myopathies have a spectrum of histopathological phenotypes and show distinct complement attack complex deposition patterns. Both correlate in some cases with the serological subtypes. Most cases do not show typical histological features associated with dermatomyositis (e.g. perifascicular atrophy). In contrast, more than half show relatively mild histopathological changes.

摘要

目的

最近,青少年特发性炎性肌病已重新分类为临床血清学亚组。这些亚组的肌肉病理相关性尚不完全清楚。

方法

我们通过应用国际 JDM 评分工具、肌肉病理检查和 C5b-9 补体分析,对来自英国 JDM 队列和生物标志物研究的 101 例经临床和血清学定义的青少年特发性炎性肌病患儿的肌肉活检进行了研究。

结果

90/101 例病例可获得自身抗体数据,其中 18/90 例抗 TIF1γ 阳性、15/90 例抗 NXP2 阳性、11/90 例抗 MDA5 阳性、5/90 例抗 Mi2 阳性和 6/90 例抗 PM-Scl 阳性。抗 MDA5 组的 JDM 活检严重程度评分始终较低,抗 Mi2 组较高,而其他组则广泛分布。活检根据组织学表现分为束周萎缩(22/101)、巨噬细胞丰富性坏死(6/101)、散在性坏死(2/101)、簇状坏死(2/101)、炎性纤维浸润(2/101)、慢性肌病性改变(1/101)、弥漫性内肌层巨噬细胞浸润(40/101)和微小改变(24/101)。MDA5 病例与微小改变组分离,无毛细血管 C5b-9 沉积。Mi2 组显示出较高的严重程度评分和肌膜补体沉积的趋势。NXP2 和 TIF1γ 组表现出多种病理改变,弥漫性内肌层巨噬细胞浸润比例高,毛细血管 C5b-9 沉积比例高。

结论

我们已经表明,青少年特发性炎性肌病具有一系列组织病理学表型,并显示出不同的补体攻击复合物沉积模式。在某些情况下,两者与血清学亚型相关。大多数病例没有显示出与皮肌炎相关的典型组织学特征(例如束周萎缩)。相反,超过一半的病例显示相对轻微的组织病理学变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/532054a28156/NAN-45-495-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/ccdab6ca0160/NAN-45-495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/7d8b17fd6f44/NAN-45-495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/e2e419cb08f3/NAN-45-495-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/78467ae6082f/NAN-45-495-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/3cd1ae4e1306/NAN-45-495-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/532054a28156/NAN-45-495-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/ccdab6ca0160/NAN-45-495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/7d8b17fd6f44/NAN-45-495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/e2e419cb08f3/NAN-45-495-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/78467ae6082f/NAN-45-495-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/3cd1ae4e1306/NAN-45-495-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ef7/6767402/532054a28156/NAN-45-495-g006.jpg

相似文献

1
Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.大样本临床幼年特发性炎性肌病队列的组织学异质性:肌炎自身抗体和病理特征分析。
Neuropathol Appl Neurobiol. 2019 Aug;45(5):495-512. doi: 10.1111/nan.12528. Epub 2019 Mar 11.
2
Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.免疫介导性坏死性肌病(IMNM):肌病理的挑战。
Autoimmun Rev. 2022 Feb;21(2):102993. doi: 10.1016/j.autrev.2021.102993. Epub 2021 Nov 16.
3
Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups.青少年皮肌炎自身抗体亚组中的不同组织损伤模式。
Acta Neuropathol Commun. 2020 Aug 5;8(1):125. doi: 10.1186/s40478-020-01007-3.
4
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.青少年特发性炎性肌病的肌炎自身抗体表型
Medicine (Baltimore). 2013 Jul;92(4):223-243. doi: 10.1097/MD.0b013e31829d08f9.
5
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.基于临床表现和肌炎特异性自身抗体的特发性炎性肌病新分类系统的建立。
JAMA Neurol. 2018 Dec 1;75(12):1528-1537. doi: 10.1001/jamaneurol.2018.2598.
6
Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.四种特发性炎性肌病相关的自身抗体-抗 TIF1γ、抗 NXP2、抗 SAE 和抗 MDA5-在匈牙利特发性炎性肌病患者(成人和青少年)队列中。
Autoimmun Rev. 2014 Dec;13(12):1211-9. doi: 10.1016/j.autrev.2014.08.011. Epub 2014 Aug 23.
7
Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.抗 Jo-1 抗体阳性的患者表现出特征性的坏死性束周性肌炎。
Brain. 2015 Sep;138(Pt 9):2485-92. doi: 10.1093/brain/awv192. Epub 2015 Jul 21.
8
The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies.特发性炎性肌病中肌炎特异性自身抗体与肌肉病变之间的关联。
Clin Rheumatol. 2021 Feb;40(2):613-624. doi: 10.1007/s10067-020-05274-2. Epub 2020 Jul 15.
9
Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience.炎症性肌病中肌肉活检特征与肌炎自身抗体的比较:一项初步经验
Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):408-418. doi: 10.4103/aian.aian_142_23. Epub 2023 Aug 25.
10
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling.抗 MDA5 少年特发性炎性肌病:干扰素-α信号差异增强定义的特定亚群。
Rheumatology (Oxford). 2020 Aug 1;59(8):1927-1937. doi: 10.1093/rheumatology/kez525.

引用本文的文献

1
The role of monocytes and macrophages in idiopathic inflammatory myopathies: insights into pathogenesis and potential targets.单核细胞和巨噬细胞在特发性炎性肌病中的作用:对发病机制和潜在靶点的见解
Front Immunol. 2025 Mar 20;16:1567833. doi: 10.3389/fimmu.2025.1567833. eCollection 2025.
2
An update on autoantibodies in the idiopathic inflammatory myopathies.特发性炎症性肌病中自身抗体的最新进展。
Nat Rev Rheumatol. 2025 Jan;21(1):46-62. doi: 10.1038/s41584-024-01188-4. Epub 2024 Nov 28.
3
Expert Perspective: Diagnostic Approach to Differentiating Juvenile Dermatomyositis From Muscular Dystrophy.

本文引用的文献

1
224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016.第224届ENMC国际研讨会:免疫介导性坏死性肌病的临床-血清学-病理学分类,荷兰赞德福特,2016年10月14日至16日。
Neuromuscul Disord. 2018 Jan;28(1):87-99. doi: 10.1016/j.nmd.2017.09.016. Epub 2017 Oct 23.
2
Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.儿童抗信号识别颗粒相关肌炎的有效诱导治疗:一项小病例系列研究及文献综述
Pediatr Rheumatol Online J. 2017 Oct 31;15(1):77. doi: 10.1186/s12969-017-0205-x.
3
专家视角:区分青少年皮肌炎与肌营养不良症的诊断方法
Arthritis Rheumatol. 2025 May;77(5):506-520. doi: 10.1002/art.43057. Epub 2025 Jan 6.
4
Juvenile Dermatomyositis: Updates in Pathogenesis and Biomarkers, Current Treatment, and Emerging Targeted Therapies.青少年皮肌炎:发病机制与生物标志物的最新进展、当前治疗方法及新兴靶向治疗
Paediatr Drugs. 2025 Jan;27(1):57-72. doi: 10.1007/s40272-024-00658-2. Epub 2024 Oct 19.
5
Cutaneous Ulcers and Response to Treatment in a Child with Anti-MDA5 Dermatomyositis.一名抗MDA5皮肌炎患儿的皮肤溃疡及治疗反应
Mediterr J Rheumatol. 2024 May 21;35(2):309-310. doi: 10.31138/mjr.191123.cua. eCollection 2024 Jun.
6
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients.TIF1-γ IgG2 亚型与青少年皮肌炎患者的恶性肿瘤无关。
Rheumatology (Oxford). 2024 Oct 1;63(10):e281-e284. doi: 10.1093/rheumatology/keae182.
7
Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies.特发性炎性肌病患者不同肌炎特异性自身抗体中外周血单个核细胞和单核细胞中 1 型干扰素特征。
Front Immunol. 2023 May 9;14:1169057. doi: 10.3389/fimmu.2023.1169057. eCollection 2023.
8
Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care.幼年特发性关节炎:病理生理学和临床治疗的最新进展。
Nat Rev Rheumatol. 2023 Jun;19(6):343-362. doi: 10.1038/s41584-023-00967-9. Epub 2023 May 15.
9
Dermatomyositis With Dual Positive Anti-melanoma Differentiation-Associated Gene 5 and Anti-Sjogren Syndrome-Related Antigen 52 kD Antibodies: A Case Report and Literature Review on Clinical Characteristics.伴抗黑色素瘤分化相关基因5和抗干燥综合征相关抗原52 kD抗体双阳性的皮肌炎:一例报告及临床特征文献综述
Cureus. 2023 Jan 26;15(1):e34235. doi: 10.7759/cureus.34235. eCollection 2023 Jan.
10
Cardiac involvement in anti-MDA5 dermatomyositis: a case-based review.抗 MDA5 皮肌炎的心脏受累:基于病例的综述。
Clin Rheumatol. 2023 Mar;42(3):949-958. doi: 10.1007/s10067-022-06401-x. Epub 2022 Dec 1.
Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
青少年特发性炎性肌病中的抗HMGCR自身抗体可识别出一小部分罕见但具有临床重要性的患者。
J Rheumatol. 2017 Apr;44(4):488-492. doi: 10.3899/jrheum.160871. Epub 2017 Feb 15.
4
Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.抗3-羟基-3-甲基戊二酰辅酶A还原酶自身抗体与DRB1*07:01及青少年肌炎患者严重肌炎的关联
Arthritis Care Res (Hoboken). 2017 Jul;69(7):1088-1094. doi: 10.1002/acr.23113.
5
Integrated classification of inflammatory myopathies.炎症性肌病的综合分类。
Neuropathol Appl Neurobiol. 2017 Feb;43(1):62-81. doi: 10.1111/nan.12380.
6
Anti-TIF1-γ antibody and cancer-associated myositis: A clinicohistopathologic study.抗 TIF1-γ 抗体与癌相关性肌炎:一项临床组织病理学研究。
Neurology. 2016 Jul 19;87(3):299-308. doi: 10.1212/WNL.0000000000002863. Epub 2016 Jun 24.
7
Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.肌肉活检结果与肌炎特异性自身抗体联合有助于预测幼年皮肌炎的结局。
Arthritis Rheumatol. 2016 Nov;68(11):2806-2816. doi: 10.1002/art.39753. Epub 2016 Oct 9.
8
The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.青少年特发性炎性肌病:发病机制、临床及自身抗体表型与预后
J Intern Med. 2016 Jul;280(1):24-38. doi: 10.1111/joim.12444. Epub 2016 Mar 30.
9
Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.伴或不伴抗黑色素瘤分化相关基因5抗体的皮肌炎:共同的干扰素特征但不同的NOS2表达
Am J Pathol. 2016 Mar;186(3):691-700. doi: 10.1016/j.ajpath.2015.11.010. Epub 2016 Jan 21.
10
The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.在皮肌炎患者的肌肉活检中,个体组织病理学特征的患病率因自身抗体状态而异。
J Rheumatol. 2015 Aug;42(8):1448-54.